How COVID unlocked the power of RNA vaccines.

Dolgin, Elie

Dolgin, Elie.

Nature ; 589(7841): 189-191, 2021 01.

Article in English | MEDLINE | ID: covidwho-1038196

Subject(s)

COVID-19 Vaccines/immunology; COVID-19/immunology; COVID-19/prevention & control; Vaccines, Synthetic/immunology; Vaccinology/trends; Animals; COVID-19 Vaccines/administration & dosage; COVID-19 Vaccines/adverse effects; Device Approval/legislation & jurisprudence; Germany; HIV Infections/immunology; HIV Infections/prevention & control; Humans; Immunization Schedule; Influenza, Human/immunology; Influenza, Human/prevention & control; Influenza, Human/virology; Malaria/immunology; Malaria/prevention & control; Mice; Nanoparticles/administration & dosage; Nanoparticles/chemistry; RNAi Therapeutics/methods; Rats; SARS-CoV-2/immunology; Time Factors; Tuberculosis/immunology; Tuberculosis/prevention & control; United States; Vaccines, Synthetic/administration & dosage; Vaccines, Synthetic/adverse effects

Keywords

Drug discovery; Immunology; SARS-CoV-2; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines, Synthetic / Vaccinology / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Animals / Humans Country/Region as subject: North America / Europa Language: English Journal: Nature Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google